Jason Cavalier insider trades
Open-market stock purchases and sales by Jason Cavalier, Principal Financial Officer at Lyra Therapeutics, Inc, from SEC Form 4 filings since Sep 13, 2021.
Companies traded
- LYRA Lyra Therapeutics, Inc: 2 sales, last Apr 1, 2026